Verve Therapeutics's total assets for Q1 2025 were $614.16M, a decrease of -5.13% from the previous quarter. VERV total liabilities were $140.65M for the fiscal quarter, a -8.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.